Interferon-alpha: an efficacious immune-modulating therapy for ulcerative colitis?
Baert
F
F
Inflammatory Bowel Disease Research Unit, University Hospital, Leuven, Belgium.
Rutgeerts
P
P
D003093:Colitis, Ulcerative / Q000276:immunology / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012074:Remission Induction; D012107:Research Design; D013997:Time Factors
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins